89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.
|Year||Equity||Revenue||EBITDA||Fin. Res.||Net Inc.||Net Mar.||ROE||Cash||Debt||N.D. / EBITDA||OCF||CAPEX||FCF||Free||Div.|
The values above are represented in USD and the scale is in millions—10.000 is the equivalent of 10 billions. L inside the table means Loss.